New research shows prenatal PFAS exposure increases maternal insulin resistance and beta-cell dysfunction, with EU regulators proposing stricter limits as clinical trials explore interventions. June 2...
A May 2024 cohort study reveals prenatal PFAS exposure reduces maternal beta cell function by 15-20%, increasing diabetes risk. EU proposals and NIH funding highlight urgent public health responses. R...
A May 2024 study in *Environmental Health Perspectives* connects prenatal PFAS exposure to impaired maternal beta cell function, while new EPA regulations and EU reports intensify global regulatory ac...
June 2024 research demonstrates prenatal PFAS exposure disrupts pancreatic beta cell function, increasing diabetes risk. EFSA slashes safety limits by 80% as EWG urges pregnancy precautions. Emerging ...
New research reveals prenatal PFAS exposure disrupts maternal beta cell function, increasing diabetes risk, with significant socioeconomic disparities in exposure levels. Recent studies show prenatal ...
NIH-funded research shows prenatal PFAS exposure increases maternal beta-cell dysfunction risk by 15-20% a decade postpartum, with epigenetic changes as a key mechanism. Emerging evidence connects pre...
New research shows prenatal PFAS exposure disrupts maternal beta cell function, increasing gestational diabetes risk by 30%, with long-term metabolic consequences. Emerging evidence reveals PFAS chemi...
Recent research shows prenatal PFAS exposure disrupts maternal beta cell function, increasing diabetes risk years after pregnancy, with significant public health implications. Groundbreaking study rev...
New research reveals prenatal PFAS exposure may impair maternal beta cell function long-term, increasing diabetes risk amid widespread contamination concerns. Groundbreaking study connects prenatal PF...
New research shows prenatal PFAS exposure reduces maternal HOMA-β by 34%, with epigenetic and oxidative stress markers providing mechanistic insights. Global regulatory responses are evolving. A grou...
